Yeah that language doesn’t ooze confidence
- Forums
- ASX - By Stock
- PAR
- LiveStream: Paradigm Biopharma (ASX:PAR) pursuing FDA review
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
0.00%
!
43.0¢

LiveStream: Paradigm Biopharma (ASX:PAR) pursuing FDA review, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
43.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $170.8M |
Open | High | Low | Value | Volume |
43.0¢ | 43.0¢ | 41.5¢ | $141.6K | 337.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9738 | 41.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
43.0¢ | 76716 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9738 | 0.415 |
4 | 53856 | 0.410 |
2 | 13595 | 0.405 |
7 | 114000 | 0.400 |
2 | 33076 | 0.395 |
Price($) | Vol. | No. |
---|---|---|
0.430 | 66716 | 3 |
0.435 | 1447 | 1 |
0.440 | 89875 | 4 |
0.445 | 11400 | 2 |
0.450 | 92730 | 8 |
Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online